JUN and neoplasm: We found that the expression levels of all components of the SHP2-ASK1-c-Jun-SOX7 signaling axis were upregulated or activated in tumor-associated endothelial cells, highlighting the importance of this signaling axis in controlling tumor angiogenesis and vessel abnormality.